 | Up a level |
Gautschi, Oliver; Ratschiller, Daniel; Gugger, Mathias; Betticher, Daniel C; Heighway, Jim (2007). Cyclin D1 in non-small cell lung cancer: a key driver of malignant transformation. Lung cancer, 55(1), pp. 1-14. Amsterdam: Elsevier 10.1016/j.lungcan.2006.09.024
Gautschi, O; Huegli, B; Ziegler, A; Gugger, M; Heighway, J; Ratschiller, D; Mack, P C; Gumerlock, P H; Kung, H J; Stahel, R A; Gandara, D R; Betticher, D C (2007). Origin and prognostic value of circulating KRAS mutations in lung cancer patients. Cancer letters, 254(2), pp. 265-73. Amsterdam: Elsevier 10.1016/j.canlet.2007.03.008
Gautschi, Oliver; Hugli, Barbara; Ziegler, Annemarie; Bigosch, Colette; Bowers, Naomi L; Ratschiller, Daniel; Jermann, Monika; Stahel, Rolf A; Heighway, Jim; Betticher, Daniel C (2006). Cyclin D1 (CCND1) A870G gene polymorphism modulates smoking-induced lung cancer risk and response to platinum-based chemotherapy in non-small cell lung cancer (NSCLC) patients. Lung cancer, 51(3), pp. 303-11. Amsterdam: Elsevier 10.1016/j.lungcan.2005.10.025
Betticher, D. C.; Ratschiller, D.; Hsu Schmitz, S.-F.; Von Rohr, A.; Hess, U.; Zulian, G.; Wernli, M.; Tichelli, A.; Tobler, A.; Fey, M. F.; Cerny, T. (1998). Reduced dose of subcutaneous cladribine induces identical response rates but decreased toxicity in pretreated chronic lymphocytic leukaemia. Annals of oncology, 9(7), pp. 721-726. Oxford University Press 10.1023/A:1008273131598
